Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow–Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?